These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36372133)

  • 1. Patient-reported outcomes following a break in ophthalmic botulinum toxin therapy during the COVID-19 pandemic.
    Jamison A; Favor M; Malhotra R
    Can J Ophthalmol; 2024 Feb; 59(1):e41-e45. PubMed ID: 36372133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient-initiated treatment model for blepharospasm and hemifacial spasm: a randomized controlled trial.
    Lawes-Wickwar S; McBain H; Brini S; Hirani SP; Hurt CS; Flood C; Dunlop N; Solly D; Crampton B; Newman SP; Ezra DG
    BMC Neurol; 2022 Mar; 22(1):99. PubMed ID: 35300599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative crossover study on the treatment of hemifacial spasm and blepharospasm: preseptal and pretarsal botulinum toxin injection techniques.
    Lolekha P; Choolam A; Kulkantrakorn K
    Neurol Sci; 2017 Nov; 38(11):2031-2036. PubMed ID: 28884242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm.
    Cannon PS; MacKenzie KR; Cook AE; Leatherbarrow B
    Clin Exp Ophthalmol; 2010 Oct; 38(7):688-91. PubMed ID: 20456439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
    JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N; Bilen Ş; Topçu Yılmaz P; Evren Kemer Ö
    Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Injection Botulinum Toxin in Blepharospasm.
    Amatya M; Limbu B; Sthapit PR; Gurung HB; Saiju R
    Nepal J Ophthalmol; 2021 Jan; 13(25):40-49. PubMed ID: 33981096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P; Chaudhary M; Agrawal JP; Shah DN
    Kathmandu Univ Med J (KUMJ); 2010; 8(31):305-10. PubMed ID: 22610735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.
    Lai KKH; Tsang A; Kuk AKT; Ko CKL; Chan E; Ko STC
    Neuroophthalmology; 2021; 45(5):293-300. PubMed ID: 34566211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
    Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
    Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia.
    Bladen JC; Feldman I; Favor M; Dizon M; Litwin A; Malhotra R
    Eye (Lond); 2019 Mar; 33(3):349-352. PubMed ID: 30202071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switchover study of onabotulinumtoxinA to incobotulinumtoxinA for facial dystonia.
    Bladen JC; Favor M; Litwin A; Malhotra R
    Clin Exp Ophthalmol; 2020 Dec; 48(9):1146-1151. PubMed ID: 32710447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy.
    Alexandru H; Muthuraman M; Chirumamilla VC; Koirala N; Paktas B; Deuschl G; Zeuner KE; Groppa S
    PLoS One; 2016; 11(12):e0168652. PubMed ID: 27992533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study.
    Hirunwiwatkul P; Supawatjariyakul W; Jariyakosol S; Apinyawasisuk S; Sriratanaban J; Chongpison Y; Jagota P; Aui-Aree N; Witthayaweerasak J; Setthawatcharawanich S; Kitthaweesin K; Chirapapaisan N; Chaimongkoltrakul P; Laowanapiban P; Hansapinyo L; Panpitpat S; Kurathong S; Nimworaphan J; Thitiwichienlert S; Vanikieti K; Samipak N; Srimanan W; Mekhasingharak N; Chaitanuwong P
    PLoS One; 2023; 18(3):e0283111. PubMed ID: 36920965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
    Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which factors impact on quality of life for adults with blepharospasm and hemifacial spasm?
    Lawes-Wickwar S; McBain H; Hirani SP; Hurt CS; Dunlop N; Solly D; Crampton B; Newman SP; Ezra DG
    Orbit; 2021 Apr; 40(2):110-119. PubMed ID: 32116098
    [No Abstract]   [Full Text] [Related]  

  • 18. Facial dystonias and rosacea: is there an association?
    Khan TT; Donaldson J; Hesse RJ
    Orbit; 2014 Aug; 33(4):276-9. PubMed ID: 24831933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A; Barman CR; Prabhakar S
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.